Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- BANB.SW
- Price
- 70.70
- Stock movement up
- +0.35 (0.55%)
- Company name
- Bachem Holding AG
- Exchange
- (SW ,
- Currency
- CHF )
- Sector
- Basic Materials >Chemicals
- Market cap
- 4.82B
- Ent value
- 5.34B
- Price/Sales
- 3.84
- Price/Book
- 3.54
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -15.08%
- Trailing P/E
- 19.44
- Forward P/E
- 26.81
- PEG
- -
- EPS growth
- 15.42%
- 1 year return (CAGR)
- 14.53%
- 3 year return (CAGR)
- -9.61%
- 5 year return (CAGR)
- -2.84%
- 10 year return (CAGR)
- 19.97%
Last updated: 2026-02-13
DIVIDENDS
BANB.SW does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 19.44 |
| Price to OCF | 12.38 |
| Price to FCF | - |
| Price to EBITDA | 13.39 |
| EV to EBITDA | 14.84 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 3.84 |
| Price to Book | 3.54 |
| EV to Sales | 4.25 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 74.98M |
| EPS (TTM) | 3.30 |
| FCF per share (TTM) | -2.26 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 1.26B |
| Gross profit (TTM) | 391.05M |
| Operating income (TTM) | 293.06M |
| Net income (TTM) | 247.76M |
| EPS (TTM) | 3.30 |
| EPS (1y forward) | 2.39 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 31.14% |
| Operating margin (TTM) | 23.34% |
| Profit margin (TTM) | 19.73% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 29.14M |
| Net receivables | 184.19M |
| Total current assets | 710.60M |
| Goodwill | 0.00 |
| Intangible assets | 23.05M |
| Property, plant and equipment | 0.00 |
| Total assets | 1.91B |
| Accounts payable | 32.21M |
| Short/Current long term debt | 60.87M |
| Total current liabilities | 291.56M |
| Total liabilities | 550.82M |
| Shareholder's equity | 1.36B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 389.09M |
| Capital expenditures (TTM) | 558.24M |
| Free cash flow (TTM) | -169.16M |
| Dividends paid (TTM) | 25.50M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 18.22% |
| Return on Assets | 12.97% |
| Return on Invested Capital | 17.44% |
| Cash Return on Invested Capital | -11.91% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 64.60 |
| Daily high | 64.95 |
| Daily low | 63.55 |
| Daily Volume | 98K |
| All-time high | 167.60 |
| 1y analyst estimate | 76.59 |
| Beta | 1.07 |
| EPS (TTM) | 3.30 |
| Dividend per share | 0.00 |
| Ex-div date | 5 May 2025 |
| Next earnings date | 12 Mar 2026 |
Downside potential
Loading...
Downside potential data
| BANB.SW | S&P500 | |
| Current price drop from All-time high | -57.82% | -0.89% |
| Highest price drop | -83.38% | -56.47% |
| Date of highest drop | 28 Dec 2011 | 9 Mar 2009 |
| Avg drop from high | -50.98% | -10.86% |
| Avg time to new high | 50 days | 12 days |
| Max time to new high | 4955 days | 1805 days |
COMPANY DETAILS
Marketcap
4.82B
Marketcap category
Mid-cap
Description
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was incorporated in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.
Employees
2292
Website
Investor relations
-
SEC filings
CEO
Country
Switzerland
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
January 7, 2026
Key Insights The projected fair value for Bachem Holding is CHF36.15 based on 2 Stage Free Cash Flow to Equity Bachem...
November 19, 2025
BERLIN - November 3, 2025 (NEWMEDIAWIRE) - The Supervisory Board of Medios AG has appointed Thomas Meier as a member of the Executive Board with effect from February 1, 2026, and designated him the ne...
November 3, 2025
Bubendorf, Switzerland--(Newsfile Corp. - October 31, 2025) - Ad hoc announcement pursuant to Art. 53 LR Anne-Kathrin Stoller to become new CEO at Bachem Bachem (SIX: BANB) announced today that its Bo...
October 31, 2025
The capacity expansion in Bubendorf reached another important milestone with the inspection of Building K. The announced start-up is proceeding according to plan. In Vista, CA, Bachem acquired a prope...
October 23, 2025
While Bachem Holding AG ( VTX:BANB ) might not have the largest market cap around , it saw significant share price...
October 22, 2025
Key Insights Bachem Holding's significant insider ownership suggests inherent interests in company's expansion Peter...
October 1, 2025
While not a mind-blowing move, it is good to see that the Bachem Holding AG ( VTX:BANB ) share price has gained 14% in...
September 11, 2025
Most readers would already be aware that Bachem Holding's (VTX:BANB) stock increased significantly by 32% over the past...
August 25, 2025
Bubendorf, Switzerland--(Newsfile Corp. - August 20, 2025) - The Bachem Group (SIX: BANB) announced today that Hans Van Hees, currently Chief Operations Officer Europe, will take on the role of Chief ...
August 20, 2025
Next page